4
Changes in Ownership
IRulya Therapeutics Inc. Filed Acc 0001209191-22-001752
Options or other derivatives
- Chief Medical Officer acquired 125,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Detke Michael J. · Chief Medical Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-01-03 | Grant or award : show line 1 in the form Stock Option (right to buy) | +125,000 | 125,000 | D |
Loading xslF345X03/doc4.xml…